Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Longitudinal predictors of uremic pruritus.

Shirazian S, Kline M, Sakhiya V, Schanler M, Moledina D, Patel C, Hazzan A, Fishbane S.

J Ren Nutr. 2013 Nov;23(6):428-31. doi: 10.1053/j.jrn.2013.08.002.

PMID:
24209894
2.

Uremic pruritus and serum phosphorus level.

Gatmiri SM, Mahdavi-Mazdeh M, Lessan-Pezeshki M, Abbasi M.

Acta Med Iran. 2013 Aug 7;51(7):477-81.

3.

Uremic pruritus: roles of parathyroid hormone and substance P.

Cho YL, Liu HN, Huang TP, Tarng DC.

J Am Acad Dermatol. 1997 Apr;36(4):538-43.

PMID:
9092738
4.

Relationship between serum intact parathyroid hormone and pruritus in hemodialysis patients.

Makhlough A, Emadi N, Sedighi O, Khademloo M, Bicmohamadi AR.

Iran J Kidney Dis. 2013 Jan;7(1):42-6.

5.

Association between pruritus and serum concentrations of parathormone, calcium and phosphorus in hemodialysis patients.

Tajbakhsh R, Joshaghani HR, Bayzayi F, Haddad M, Qorbani M.

Saudi J Kidney Dis Transpl. 2013 Jul;24(4):702-6.

6.

The effect of ergocalciferol on uremic pruritus severity: a randomized controlled trial.

Shirazian S, Schanler M, Shastry S, Dwivedi S, Kumar M, Rice K, Miyawaki N, Ghosh S, Fishbane S.

J Ren Nutr. 2013 Jul;23(4):308-14. doi: 10.1053/j.jrn.2012.12.007. Epub 2013 Feb 27.

PMID:
23453391
7.

Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?

Friga V, Linos A, Linos DA.

Nephron. 1997;75(1):48-53.

PMID:
9031270
9.

Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients.

Noordzij M, Boeschoten EW, Bos WJ, Dekker FW, Bossuyt PM, Krediet RT, Korevaar JC; NECOSAD Study Group.

Nephrol Dial Transplant. 2007 Oct;22(10):2944-9. Epub 2007 Jun 27.

10.

Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy.

Blachley JD, Blankenship DM, Menter A, Parker TF 3rd, Knochel JP.

Am J Kidney Dis. 1985 May;5(5):237-41.

PMID:
4003393
11.

Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus.

Chen YC, Chiu WT, Wu MS.

Am J Kidney Dis. 2006 Jul;48(1):69-76.

PMID:
16797388
12.

Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.

Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.

Am J Nephrol. 2008;28(1):97-106. Epub 2007 Oct 3.

PMID:
17914251
13.

Uremic pruritus. Clinical and experimental studies.

Ståhle-Bäckdahl M.

Acta Derm Venereol Suppl (Stockh). 1989;145:1-38.

PMID:
2773616
14.
16.

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis.

Martin KJ, González EA, Gellens M, Hamm LL, Abboud H, Lindberg J.

J Am Soc Nephrol. 1998 Aug;9(8):1427-32.

17.

Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.

Lucchi L, Carboni C, Stipo L, Malaguti V, Ferrari F, Graziani R, Arletti S, Graziosi C.

Artif Organs. 2011 Dec;35(12):1186-93. doi: 10.1111/j.1525-1594.2011.01270.x. Epub 2011 Aug 17.

PMID:
21848793
18.
19.

Substance P and intensity of pruritus in hemodialysis and peritoneal dialysis patients.

Snit M, Gawlik R, Łącka-Gaździk B, Kuźniewicz R, Dwornicki M, Owczarek A, Walaszczyk M, Grabiec P, Grzeszczak W.

Med Sci Monit. 2013 Sep 2;19:723-32. doi: 10.12659/MSM.889349.

20.

Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2.

Llach F, Keshav G, Goldblat MV, Lindberg JS, Sadler R, Delmez J, Arruda J, Lau A, Slatopolsky E.

Am J Kidney Dis. 1998 Oct;32(2 Suppl 2):S48-54.

PMID:
9808143
Items per page

Supplemental Content

Write to the Help Desk